The Department of Medicine
Ronald H. Lands, MD
Clinical Professor
Division of Hematology and Oncology
Clinical Focus
Hematology and Oncology in the elderly, Palliative Care, Medical Ethics, Narrative Medicine
Education
Medical School
University of Tennessee, Memphis
Graduate School
Master of Fine Arts, Queen’s University of Charlotte, Charlotte, NC
Residency
University of Tennessee Center for Health Sciences, Memphis, TN
Fellowship
University of Tennessee Center for Health Sciences
Certifications
Diplomate, American Board of Internal Medicine
Diplomate, American Board of Medical Oncology
Diplomate, American Board of Hematology
Certificate of added qualifications, Geriatric Medicine
American Board of Hospice/Palliative Medicine
Professional Affiliations
Current Publications
Wall JS, Kennel SJ, Stuckey A,Whittle B, Jackson JW, Williams AD, Hancock T, R. Heidel R, Mehmood M, Kassira A, Lands RH, Watson H, Hung R, Martin EB.
Preliminary observations using 99m-Tc-peptide P5+14 for the detection of AL amyloidosis using SPECT/CT and planar gamma scintigraphic imaging. Blood. 2024,Volume 144, Supplement 1,Page 1910,ISSN 0006-4971,https://doi.org/10.1182/blood-2024-207978.
Wall JS, Kennel SJ, Stuckey A, Richey T, Williams AD, Balachandran M, Hancock T, Jackson JW, Wooliver DC, Macy S, Heidel ER, Lands RH, Martin EB.
Characterization of AT02 bioactivity and an assessment of its potential use as an amyloid-clearing therapeutic for AL amyloidosis. Blood. 2024,Volume 144, Supplement 1,,Page 4641,ISSN 0006-4971, https://doi.org/10.1182/blood-2024-208282.
Martin EB, Stuckey A, Heidel ER, Whittle B, Kassira A, Lands R, Watson H, Raj R, Powell D, Kennel S, Wall JS.
Amyloid imaging with 124I-evuzamitide can detect temporal changes in systemic amyloid load and correlates with echocardiographic parameters in patients with AL or ATTR amyloidosis. Journal of Nuclear Cardiology. 2024,Volume 38, Supplement,101938,ISSN 1071-3581,https://doi.org/10.1016/j.nuclcard.2024.101938.
Wall J, Martin E, Stuckey A, Whittle B, Jackson J, Williams A, Hancock T, Heidel ER, Mehmood M, Kassira A, Lands R, Watson H, Hung R, Kennel S.
Preliminary evaluation of 99mTc-labeled peptide P5+14 for the detection of cardiopulmonary amyloidosis using SPECT/CT and planar gamma scintigraphic imaging. Journal of Nuclear Medicine. Jun 2024, 65 (supplement 2) 241277
Lands R, Martin EB, Powell D, Stuckey A, Whittle B, Guthrie S, Raj R, Kennel SJ, Wall JS.
Longitudinal PET/CT imaging with iodine ((124)i) evuzamitide reveals organ response to plasma cell immunotherapy in a patient with AL amyloidosis. Amyloid. 2024 Jun;31(2):148-149. doi: 10.1080/13506129.2023.2286427. Epub 2023 Nov 22.
Wall J, Martin E , Heidel R, Stuckey A, Whittle B, Jackson J, Williams A, Mehmood M, Kanderian A, Rebecca K, Hung R, Lands R, Kennel S.
Detection of amyloid cardiomyopathy in patients with systemic ATTR and AL amyloidosis using SPECT/CT and planar imaging of a technetium-99m-labeled peptide - technetium-99m (99mTc) evuzamitide. Journal of the American College of Cardiology . 2024 Apr, 83 (13_Supplement) 1369.https://doi.org/10.1016/S0735-1097(24)03359-X
Wall JS, Martin EB, Lands R, Ramchandren R, Stuckey A, Heidel RE, Whittle B, Powell D, Richey T, Williams AD, Foster JS, Guthrie S, Kennel SJ.
Cardiac amyloid detection by PET/CT imaging of iodine ((124)i) evuzamitide ((124)i-p5+14): A phase 1/2 study. JACC Cardiovasc Imaging. 2023 Nov;16(11):1433-1448. doi: 10.1016/j.jcmg.2023.08.009.
Martin EB, Stuckey A, Powell D, Lands R, Whittle B, Wooliver C, Macy S, Foster JS, Guthrie S, Kennel SJ, Wall JS.
Clinical confirmation of pan-amyloid reactivity of radioiodinated peptide (124)I-p5+14 (AT-01) in patients with diverse types of systemic amyloidosis demonstrated by PET/CT imaging. Pharmaceuticals (Basel). 2023 Apr 21;16(4):629. doi: 10.3390/ph16040629.
Wall JS, Martin EB, Endsley A, Stuckey AC, Williams AD, Powell D, Whittle B, Hall S, Lambeth TR, Julian RR, Stabin M, Lands RH, Kennel SJ.
First in human evaluation and dosimetry calculations for peptide (124)I-p5+14-a novel radiotracer for the detection of systemic amyloidosis using PET/CT imaging. Mol Imaging Biol. 2022 Jun;24(3):479-488. doi: 10.1007/s11307-021-01681-2. Epub 2021 Nov 16.